Daito Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients (APIs) for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company also engages in wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. Daito Pharmaceutical Co., Ltd. was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co., Ltd. in 1992. Daito Pharmaceutical Co., Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
Research context
Daito Pharmaceutical Co.,Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Daito Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 7.1% below its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Daito Pharmaceutical Co.,Ltd's total revenue rose by 6.4% to $12B since the same quarter in the previous year.
Its net income has increased by 1.8% to $1B since the same quarter in the previous year.
Based on the above factors, Daito Pharmaceutical Co.,Ltd gets an overall score of 3/5.